We were disappointed to learn that the Galleri multi-cancer early detection (MCED) test, developed by GRAIL, did not meet the primary endpoint in its large randomized trial conduct...
Receive updates from Lustgarten for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on Specificfeeds.
This way you won't miss any new article from Lustgarten. Unsubscribe at any time.
Site title: Home - Lustgarten Foundation: Pancreatic Cancer Research